Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Social Stream
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Biohaven Pharmaceutical Holding Co Ltd.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
BHVN's average price target has moved up $3.6 over the prior 111 days.
Over the past 111 days, BHVN's average upside potential has been 22.1%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BHVN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 22 months, BHVN's average broker recommendation rating worsened by 0.04.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Biohaven Pharmaceutical Holding Co Ltd's average analyst price target is higher than 666.75% of them.
- BHVN has a higher upside potential (average analyst target price relative to current price) than 105.98% of Pharmaceutical Products stocks.
- BHVN has a greater number of analysts covering the stock than 653.41% of Pharmaceutical Products stocks.
- In terms of how Biohaven Pharmaceutical Holding Co Ltd fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -197.3% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biohaven Pharmaceutical Holding Co Ltd are BBIO, AXSM, and AVIR.
Is BHVN a Buy, Hold or Sell? See the POWR Ratings now!